Related Experiment Video
Updated: Jul 13, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Cutaneous tuberculosis and its pleomorphic presentations in human immunodeficiency virus-negative patients: a case
Rose Ekambi Kotto1, Grace Anita Nkoro2, Coralie Reine Mendouga Menye2
1Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon. rozkotto25@yahoo.fr.
Background:
Cutaneous tuberculosis is reported to be rare, especially in human immunodeficiency virus-negative patients but probably also underdiagnosed. This is because it presents with pictorial and anatomoclinical polymorphism. In Africa, despite tuberculosis being endemic, isolating the germ and/or obtaining histopathological confirmation constitutes a significant challenge. Literature on the clinical presentations and outcomes of patients with cutaneous tuberculosis is sparse in Cameroon and sub-Saharan Africa. This prompted us to report on the cases of cutaneous tuberculosis we encountered.
Case Presentation:
We report ten cases of cutaneous tuberculosis diagnosed in human immunodeficiency virus-negative patients from 2018 to 2022 in Cameroon. All cases included were confirmed by histology and/or laboratory test. The average age of our patients was 35.7 ± 20.3 years, with age ranges between 8 and 72 years. The sex ratio (M/F) was 1.5. The clinical forms identified were scrofuloderma (three cases), papulonecrotic tuberculid (two cases), and tuberculosis verrucosa cutis (two cases). Tubercular gumma, lupus vulgaris, and disseminated tuberculosis accounted for one case each. Under antituberculosis drugs, the clinical progress was favorable for all cases.
Conclusion:
Cutaneous tuberculosis can present in various forms. Though rare in our setting, physicians should consider this diagnosis when faced with any chronic skin lesion that does not respond to conventional treatment.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis